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Abstract—Pharmaceutical companies today face a growing 
demand for more complex drug designs. In the past few 
decades, a number of probabilistic models have been 
developed, for the purpose of giving a better insight into the 
microscopic features of these complex designs. Of particular 
interest are those models that simulate controlled release 
systems to provide targeted dose delivery. Controlled release is 
achieved by using polymers with different dissolution 
characteristics. We present here a model of a drug delivery 
system based on Monte Carlo methods, as a framework for 
Cellular Automata mobility, and show a solution for model 
enhancement through parallelisation. The objective is the high 
performance simulation of targeted drug release in the gastro-
intestinal tract, from a capsule composed of ethylcellulose 
coated microspheres. The overall aim is to understand the 
importance of various molecular effects with respect to system 
evolution over time. Important underlying mechanisms of the 
process, such as erosion and diffusion, are described. 
Keywords-Drug dissolution, Probabilistic methods, Discrete 
simulation, Computational modelling, OpenMP parallelisation 
I.  INTRODUCTION 
Pharmaceutical systems designed to transport active 
substances into the body are known as drug delivery systems 
(DDS). The computational modelling of DDS is a constantly 
developing field, with the potential to become an integral 
part of pharmaceutical research development. Newer drug 
formulations can be very complex, while influence of system 
composition and variables on the release profiles is not fully 
understood. Modern drug design processes require 
collaboration between pharmacists, bioengineers and 
computer scientists. In silico modelling addresses the main 
problems of drug development through (1) reducing 
experimental cost, (implicitly high in large amount of in vitro 
testing), (2) accelerating the time for drug progression to 
market, (3) better understanding of drug transport processes 
and (4) converting the existing approach from a descriptive 
to a predictive one. 
Controlled drug delivery systems are designed to deliver 
active substance, (i.e. drug), at the desired rate over a 
prolonged period to a targeted site in the body. Numerous 
research studies over the past three decades have resulted in 
a number of novel controlled delivery formulations, [1]. 
Control is maintained by using polymers of different 
structures, making polymer dissolution one of the most 
important problems to be solved. Here, we present an 
OpenMP based parallelisation model for simulation of 3D 
drug systems. The model is based on a combined Monte 
Carlo (MC) and Cellular Automata (CA) approach and 
simulates controlled release from coated microspheres. The 
main novelties in this work include the analysis of the effect 
of the coating structure on the drug release and the effort to 
mimic non-homogeneous dispersion of the drug, thus 
improving realism of the model. The research is performed 
in an ongoing collaboration with the industrial partner and 
aims to address the questions surrounding the release of the 
drug (cyclosporine) in targeting the gastro-intestinal (GI) 
tract. As one of a number of suitable coating materials, we 
model the use of ethylcellulose (EC), a generally non-
invasive polymer with good film-forming capabilities, 
(hence ideal for use in matrix agents), for prolonged release, 
[2]. Due to the thin layer of ethylcellulose used, a very fine 
grained model is required, prompting the need for the 
parallelisation. The reasons for choosing the particular 
parallelisation framework are outlined, together with its 
advantages and limitations compared to other industry 
standard parallelisation approaches, when applied to 
simulations of complex pharmaceutical systems. 
II. THEORY 
Theoretical models of DDS vary according to the type 
and complexity of the system, and can be generally divided 
into three broad groups: mechanistic, empirical and 
probabilistic, [3]. Probabilistic theories have the advantage 
of applying a bottom-up approach, (incorporating stochastic 
assumptions and a simplified representation of the system), 
but requiring less initial information and with the potential to 
yield better predictions compared to other, top-down 
theories. 
The first step in modelling the dissolution is to determine 
the in vitro dissolution rate under various external 
conditions. To emulate these conditions, a dissolution test 
apparatus is used, with standardised measuring methods 
outlined in the pharmacopoeias, [4], [5]. Here, metabolic 
conditions in the intestine stomach, (change of temperature, 
pH and dynamic flux), are mimicked in the paddle apparatus 
II, (USP II), by varying speed of the paddle, and monitoring, 
experimentally, their influence on the drug dissolution rate 
(Figure 1). Subsequently, model results are evaluated against 
these experimental data. 
Monte Carlo methods have numerous applications, 
ranging from fluid dynamics, space and traffic modelling and 
statistical physics generally, to financial and business 
analysis, [6], [7], [8]. In one of the first direct MC models of 
  
 
 
DDS, microstructural changes in bioerodible polymers were 
simulated [9], while MC is also often used as a framework 
for Cellular Automata movement. In a CA system, a discrete 
grid of individual cells is defined, where each cell can have 
one of a number of defined states. The behaviour of each cell 
is governed by a set of rules that describe the state 
transitions. Time is discrete, and the state at different time 
steps is defined according to local relations, [10].  
Figure 1.  Schematic representation of the USP II Paddle Apparatus  
A. Drug Dissolution Phenomena 
Important phenomena in polymeric drug delivery systems, 
and used in this work, include: (i) Diffusion - represents the 
motions of molecules from a region of higher to one of 
lower concentration i.e. flux. In the modelling of DDS, 
diffusion is often described by Fick’s laws, [11]. In one 
dimension, Fick’s first law can be represented as: 
 J = - D δc/δx 
where J is the diffusion flux, D is the diffusion coefficient 
and c is the concentration. (ii) Degradation - the process 
whereby chain scission occurs during which polymer chains 
become oligomers and monomers, facilitating easy release. 
Degradation is the first step of erosion, [12]. (iii) Erosion - 
represents the loss of material from a polymer due to 
degradation and determines the release rate of the drug, 
[13]. When a polymer erodes it leaves space for the drug to 
be released from the device, or for water penetration. Two 
types of erosion are defined, [14]: (a) Surface erosion is a 
homogeneous process and represents the stage during which 
the size of the device decreases while the shape remains 
constant; the device loses material only from its surface; (b) 
Bulk erosion is a heterogeneous process with material being 
lost from the whole device, although the size remains 
constant.  
III. CURRENT WORK 
This work builds upon a basis of a probabilistic model 
for simulation of PLGA microspheres, [15]. The DDS we are 
modelling here is a polymer coated sphere, with a 
nonhomogenously dispersed drug. The purpose of the model 
is to evaluate the drug release rates depending on different 
properties of the device with the emphasis on the influence 
of coating characteristics. The spherical geometry of the 
device is represented as a 3D grid of cells, where 
microscopic features can be investigated through transitions 
between cell states. Cells are initialised and simulated using 
Monte Carlo methods combined with Cellular Automata 
rules. Erosion and diffusion are assumed as the main release 
mechanisms (Figure 2). Each cell can have one of several 
possible states, described (Table 1). The transitions are 
influenced by the states of all nearest neighbour cells for a 
3D grid (i.e. Von Neumann neighbourhood with each cell 
having 26 neighbours). The drug is randomly dispersed 
within a gelatinous sphere in the form of "packets" where the 
latter represent quantities of drug that can diffuse in each 
simulation interval. Diffusion of the drug inside the sphere is 
represented as a random walk of packets, influenced by 
concentration differences. Each packet has probability of 
transition between neighbouring cells, weighted by the value 
of the concentration gradient, based on Fick's first law (i.e. 
the highest probability for movement will be in the direction 
of the largest concentration gradient). In the coating layer, 
scission of the polymer chains occurs and formation of pores 
follows the Erlang probability distribution, as reported in [9]. 
The rate of pore formation is characterised by a parameter , 
which defines the lifetime, t, of an individual EC cell: 
 
t = 1/λln(U), UUnif[0, 1]  
Figure 2.  Simplified Internal Morphology of one 3D Sphere Simulating 
Drug Dissolution through Coating Layer. Enlarged: Part of the Sphere with 
Definition of Model Cell Types. Bottom: Simulation Stages: Initial (left), 
Release (centre) and Dissolved (right). 
Cells erode, forming a channel through which the drug 
packet can diffuse, when cell lifetime expires. The diffusion 
through these channels occurs at a rate slower than the 
diffusion in solvent, (inside the coating layer), reflecting the 
influence of permeability of the membrane, [16]. The release 
 
 
rate is measured by counting the number of packets that 
reach the buffer zone, assuming perfect sink conditions. 
TABLE I.  CELL TYPES AND RULES OF BEHAVIOUR 
Cell type Behaviour description 
Buffer 
Drug is released when it reaches buffer zone. Cell 
type acts as a perfect sink. 
Ethylcellulose 
(EC) 
Drug-free coating layer. Assigned lifetime, based 
on λ (degradation rate) parameter. Forms an EC 
channel cell upon complete erosion. 
EC channel 
Gelatine and drug can diffuse through EC channel 
cells. 
Gelatine 
Fixed lifetime. During diffusion through solvent 
cells, facilitates movement of drug “packets”. 
Solvent 
Gelatine erodes into the solvent. Drug can diffuse 
through the latter. 
Drug packet 
Drug, initially dispersed in gelatine cells. Each cell 
can hold a maximum (saturation) amount of drug 
"packets". 
A. Model Parallelisation 
Using high performance computing facilities, (available 
in-house and at the national centre), we are reconstructing 
the model to suit a shared memory, multi-threaded paradigm 
in order to achieve short large-scale simulation times. The 
parallelisation scheme is implemented using GNU OpenMP 
(GOMP). Algorithms are coded using the C++ language and 
OpenGL libraries for graphic representation where the latter 
is useful, in particular, for the development and liaison stage. 
Initially a sequential, stochastic model for the described 
drug was implemented [17], but the dimensional analysis for 
fine-tuning of model precision required a significant number 
of simultaneous runs. However, requirements for producing 
realistic results proved to be time-consuming for large model 
scales, so parallelisation was a logical step forward in 
obtaining the speedup, with CA models particularly suited to 
this end, [18]. However, special features of the model, such 
as drug packet movement and cell-state transitions between 
the layers, appear to be non-trivial for this implementation. 
Figure 3 represents the solution for dividing 3D space into 
layers suitable for parallelisation. Due to the high 
communication demands between the layers, we chose 
OpenMP, an industry standard for shared-memory parallel 
programming [19], that has an advantage over other 
solutions, (e.g. distributed memory and message passing 
frameworks), in that all threads share the same view of the 
overall problem space. While adequate for CA 
communication problems, OpenMP is limited by the 
architecture of the hardware platform used, as it can scale up 
only to the number of processors that share the same 
memory.  
Observed also, in upgrading the model from sequential to 
parallel implementation, is the fact that the standard C++ 
linear congruential random number generator was unsuitable 
for large scale parallel models as the implementation of the 
generator forces thread locking
1
 every time the random 
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 A thread lock is a situation where one or more threads have to wait to 
enter a critical section of the code. If another thread is currently executing 
the critical section, the operating environment will block the other threads 
until the executing thread leaves it. 
number generation function is called, causing excessive 
synchronization overhead between the threads. Instead, we 
used a lock-free implementation of the Mersenne Twister 
(MT) random number generator for each thread, which 
solved the locking problem while also offering a superior 
period length, [20]. 
IV. RESULTS 
Based on the available in vitro data, initial model 
parameters were set to: (i) CA matrix size of 200 x 200 x 
200, with cell size being 10µm, i.e. simulating millimetre 
scales of coated microsphere, (ii) maximum lifetimes of 
individual cells for gelatine and ethylcellulose, namely 60 
minutes and 2 days, respectively, (iii) diameter of the 
microsphere at 1.43mm, (iv) default weight gain of EC 
coating at 5%, and (v) drug loading kept at 10.8% of the 
mass of the sphere. Unless specifically noted, these values 
were kept constant for all simulations. The averaging of the 
drug release curves for these values for 24 repeated runs 
showed negligible variation. The effectiveness of 
parallelisation to simulation speeds was measured by 
comparing total execution times for different number of 
threads (1, 3, 6 and 12). Results showed linear speedup with 
increase in the thread number. This allowed both for 
simulation at very short time intervals and examination of 
wider ranges of model parameters with the potential to yield 
deeper insight into the causes of observed system behaviour.  
Figure 3.  Parallelisation solution for microsphere geometry for the case of 
4 threads. Each thread shares boundary layer with an adjacent thread 
The main step for initial model calibration was to 
determine the most appropriate time interval for cell state 
updates, which represents the speed of drug diffusion 
characterised by its diffusion coefficient. Since coefficient 
value was not available from the literature, to our 
knowledge, the order of magnitude interval was estimated 
using dimensional analysis based on the average release 
  
 
 
 
 
speed obtained from the in vitro data and first Fick’s law. To 
find the best fit interval, we performed simulations for 
intervals between 0.5 seconds and 100 seconds, (Figure 4, 
with representative values only shown, for clarity). 
Comparing results against experimental data (Figure 5), led 
to a choice of time interval of 30 seconds for all subsequent 
simulations. This comparison showed good model 
prediction. In analysing the results, it should be remembered 
that measurements of the in vitro release rates using different 
dissolution media in USP II may have certain limitations in 
terms of sensitivity. The insolubility of the cyclosporine, 
causes fragmentational release which requires adding 
surfactants to the dissolution media in order to solubilise the 
drug. If suitable amount of surfactants is not present, 
equipment used will not be able to detect exact release rates, 
[21]. As a result, the release curve may reach a platform at 
80% of total release, (although 100% is accounted for in the 
experiment), also in agreement with simulated predictions. 
Figure 4.  Release Profiles as a Function of the Simulation Time Interval 
With respect to the physical characteristics of the device, 
release behaviour due to the effects of coating layer porosity 
was investigated. The lifetime of EC cells was varied by 
changing the λ parameter, in order to simulate different 
lifetimes of polymer chains, (Figure 6). As expected from the 
in vitro data, decreased porosity, i.e. slower chain scission 
occurring in the coating influenced slower release rate of the 
drug. Among the primary factors influencing drug 
formulation and performance is the weight gain of the 
coating. Here, we varied the coating weight gains from 4% - 
8% of the total mass, (Figure 7). The release curves 
reproduced the reduction in diffusion rate, but the impact 
was somewhat smaller than experienced in vitro. This was 
expected, to some extent, as perfect sink conditions were 
assumed, whereas these do not really occur. In reality, the 
concentration of the dissolved device material in the 
boundary layer inhibits movement of drug packets and some 
local saturation occurs. This phenomenon must be taken into 
account in future model extensions. Also, differences of only 
1% in coating thickness could be significantly more visible 
with finer model resolutions. With speedup accomplished 
using parallelisation, this will be investigated further.  
Figure 5.  Simulated vs experimental results (experimental data provided 
by Sigmoid Pharma Ltd.) 
On the other hand, the lifetime of the inner, gelatine, 
carrier can be considered negligible in terms of influence on 
final release rate, as can be seen, (Figure 8). However, 
gelatine was shown to be an important controller of the drug 
release in the initial stages, as it influences the "burst effect" 
by accelerating the buffer penetration inside the coating and 
therefore drug transfer through EC channels. 
Figure 6.  Release Profiles as a Function of the Coating Degradation Rate 
Lambda. Legend represents inverse lambda values. In brackets: equivalent 
amount of eroded EC in 24h 
V. FUTURE WORK 
With the introduction of parallelisation, the model 
became significantly more scalable, allowing fast simulation 
times at fine-grained resolutions. Current simulated results 
showed qualitatively similar behaviour to in vitro data, 
(Figure 5). Although, quantitative data is not obtained 
precisely, which is to be expected, given the simplified 
dissolution model, the overall results are promising and form 
a good base for future extensions. As noted, the modelled EC 
phenomena can not focus only on erosion, but must include 
polymer swelling due to increased hydration of broken 
polymer chains, [22]. This swelling is caused by additives to 
 
 
 
 
the coating structure. Additionally, the model needs be 
augmented to include the effect of different media 
surrounding the drug, (biphasic release), in order to mimic 
different stages of the GI tract environment. Nevertheless, 
the approach to date facilitates comparison of simulated and 
experimental release curves, allowing us to determine key 
parameters and their values for this novel formulation, and to 
reproduce qualitative behaviour and best fit.  
Figure 7.  Release Profiles as a Function of Coating Weight Gain. 
Figure 8.  Release Profiles as a Function of Gelatine Lifetime. 
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